14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.05 $4.30 Thursday, 2nd May 2024 GERN stock ended at $3.95. This is 3.19% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.38% from a day low at $3.84 to a day high of $4.20.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Feb 22, 2023 $2.82 $2.89 $2.75 $2.83 3 981 712
Feb 21, 2023 $2.76 $2.84 $2.73 $2.76 4 565 061
Feb 17, 2023 $2.72 $2.84 $2.67 $2.81 4 400 563
Feb 16, 2023 $2.68 $2.73 $2.63 $2.72 4 441 476
Feb 15, 2023 $2.64 $2.71 $2.61 $2.69 3 717 597
Feb 14, 2023 $2.76 $2.76 $2.62 $2.66 5 478 541
Feb 13, 2023 $3.00 $3.00 $2.69 $2.70 8 495 095
Feb 10, 2023 $3.01 $3.05 $2.98 $3.01 4 164 195
Feb 09, 2023 $3.10 $3.10 $3.00 $3.01 5 451 857
Feb 08, 2023 $3.18 $3.18 $3.04 $3.05 4 461 731
Feb 07, 2023 $3.23 $3.23 $3.11 $3.20 4 598 566
Feb 06, 2023 $3.22 $3.29 $3.16 $3.23 4 234 754
Feb 03, 2023 $3.30 $3.38 $3.21 $3.22 4 660 787
Feb 02, 2023 $3.40 $3.42 $3.27 $3.34 4 364 334
Feb 01, 2023 $3.31 $3.40 $3.25 $3.38 4 130 539
Jan 31, 2023 $3.21 $3.32 $3.18 $3.30 4 306 570
Jan 30, 2023 $3.33 $3.35 $3.16 $3.20 3 920 292
Jan 27, 2023 $3.38 $3.41 $3.32 $3.34 3 628 508
Jan 26, 2023 $3.39 $3.43 $3.34 $3.37 3 276 922
Jan 25, 2023 $3.36 $3.47 $3.30 $3.40 5 349 257
Jan 24, 2023 $3.28 $3.43 $3.24 $3.40 7 130 172
Jan 23, 2023 $3.22 $3.31 $3.14 $3.27 5 035 017
Jan 20, 2023 $3.10 $3.20 $2.99 $3.19 7 912 111
Jan 19, 2023 $3.10 $3.20 $3.05 $3.07 4 580 300
Jan 18, 2023 $3.20 $3.35 $3.12 $3.12 5 397 300
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT